WeVote

Bill

Bill

S 774

Requires certain health insurance policies to cover scalp cooling systems for the preservation of hair during cancer chemotherapy treatment; repealer

2025 Regular Session Introduced by Toby Stavisky

Massachusetts bill raises insurers' minimum inpatient substance-use disorder coverage from 14 to 30 days, affecting private plans and providers.

SUBSTITUTED BY A430
0
WeVote Research Nonpartisan
Bill Summary · S 774

Summary — S.774: “An Act relative to requiring insurance providers cover a minimum of 30 days for in‑patient substance abuse treatment”

Status and procedural history
- Filed as Senate Docket No. 487 (filed 01/13/2025) and submitted in the One Hundred and Ninety‑Fourth General Court (2025–2026).
- Presented by Sen. Edward J. Kennedy (First Middlesex). Read twice and referred to the Committee on Financial Services (recorded 02/27/2025).
- A committee hearing is scheduled (rescheduled): 09/09/2025 (originally 10:30 AM–12:30 PM; updated virtual end time and listed as 10:30 AM–1:00 PM in some notices).
- Notes: the bill replaces/updates prior related filings (see Senate No. 487 and similar matter in 2023–24, S.1257). The sponsor list provided in the metadata appears inconsistent with the bill text (the text names Sen. Edward J. Kennedy as the filing/presenting legislator); verify sponsors in the official legislative docket.

Purpose / intent
- To increase the minimum required length of in‑patient substance use disorder (SUD) treatment that insurers must cover from 14 days to 30 days. The stated intent is to expand insurance coverage for more sustained inpatient SUD care, aligning minimum coverage with clinical needs for a longer initial treatment period.

Key provisions (substantive changes)
- The bill amends multiple sections of chapter 258 of the Acts of 2014 by replacing the numeric figure “14” with “30” in the following sections:
- Section 9
- Section 19
- Section 21
- Section 23
- Section 25
- Section 27
- Effect: wherever chapter 258 currently requires insurers to provide a minimum of 14 days of inpatient substance abuse treatment, that minimum would become 30 days.

Who would be affected
- Insurance providers subject to chapter 258 (private health insurers regulated under Massachusetts law), including group and individual plans governed by state law.
- People insured under those plans who are seeking inpatient treatment for substance use disorders—these consumers would be entitled to a longer minimum covered inpatient stay (30 days) before being subject to coverage limits.
- Providers and inpatient treatment facilities may see changes in authorizations, billing patterns, and average length of stay.
- Employers (as plan sponsors) and premiums could be indirectly affected if insurers adjust rates to cover increased utilization/costs.

Potential impacts and considerations
- Access: likely improved access to longer initial inpatient treatment episodes for SUD, potentially improving stabilization and continuity of care.
- Cost: insurers may face higher short‑term costs per enrollee for inpatient stays; this could affect premiums or cost‑sharing structures over time.
- Clinical alignment: a 30‑day minimum may better match clinical recommendations for certain SUD treatment needs, but appropriate individualized care and step‑down services remain important.
- Implementation: the bill simply changes numeric coverage minimums in multiple statutory sections; no new enforcement mechanism or effective date is specified in the text — typically the law would take effect on enactment or a date set in the enacted statute.

Recommendation for readers
- Verify final sponsors and committee actions on the official Massachusetts legislative website (given some inconsistent metadata). Watch the Financial Services committee hearing (09/09/2025) for testimony, fiscal notes, and possible amendments that could affect scope or implementation.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.